Skip to main content
Commonwealth of Virginia branding bar cardinal logo

Virginia.gov

A design prototype by Datopian, not an official website

Find a Commonwealth Resource

Quizartinib

HealthData.Gov

Updated Oct 29, 2026

About this dataset

VANFLYTA (quizartinib) is an oral prescription tablet developed by Daiichi Sankyo Inc. for treating certain blood cancers. It works as a kinase inhibitor targeting FLT3 mutations, available in 17.7 mg and 26.5 mg strengths. This information was generated using AI and is provided for informational and research purposes only.

Data and resources (1)

  • HTML

    Quizartinib

    Access the FDA dataset for Quizartinib — ANDA 216993 submitted by Mylan Institutional LLC

    Modified Apr 29, 2026

Prototype by Datopian · not an official government website · data from data.virginia.gov